Advisors Asset Management, Inc. 10x Genomics, Inc. Transaction History

Advisors Asset Management, Inc.

  • $5.62 Billion
  • Q3 2025

A detailed history of Advisors Asset Management, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 11,368 shares of TXG stock, worth $180,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,368
Previous 11,543 1.52%
Holding current value
$180,637
Previous $133,000 0.75%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
SELL
$11.34 - $14.64 $1,984 - $2,562
-175 Reduced 1.52%
11,368 $132,000
Q2 2025

Aug 12, 2025
SELL
$7.14 - $11.73 $94,512 - $155,270
-13,237 Reduced 53.42%
11,543 $133,000
Q1 2025

May 15, 2025
SELL
$8.73 - $16.31 $7,027 - $13,129
-805 Reduced 3.15%
24,780 $216,000
Q4 2024

Feb 10, 2025
SELL
$13.18 - $21.31 $16,237 - $26,253
-1,232 Reduced 4.59%
25,585 $367,000
Q3 2024

Nov 08, 2024
SELL
$15.71 - $23.49 $10,588 - $15,832
-674 Reduced 2.45%
26,817 $605,000
Q2 2024

Aug 14, 2024
BUY
$19.45 - $37.37 $44,015 - $84,568
2,263 Added 8.97%
27,491 $534,000
Q1 2024

May 14, 2024
BUY
$36.08 - $54.3 $195,048 - $293,545
5,406 Added 27.27%
25,228 $946,000
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $420,763 - $705,563
12,260 Added 162.13%
19,822 $1.11 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $28,639 - $33,000
562 Added 8.03%
7,562 $422,000
Q1 2023

May 12, 2023
SELL
$35.33 - $55.79 $26,497 - $41,842
-750 Reduced 9.68%
7,000 $390,000
Q3 2022

Nov 08, 2022
SELL
$28.48 - $52.59 $32,552 - $60,110
-1,143 Reduced 5.59%
19,299 $550,000
Q2 2022

Aug 08, 2022
SELL
$36.95 - $82.41 $21,172 - $47,220
-573 Reduced 2.73%
20,442 $925,000
Q1 2022

May 17, 2022
SELL
$55.7 - $145.79 $48,681 - $127,420
-874 Reduced 3.99%
21,015 $1.6 Million
Q4 2021

Feb 15, 2022
BUY
$135.05 - $182.59 $328,846 - $444,606
2,435 Added 12.52%
21,889 $3.26 Million
Q3 2021

Nov 12, 2021
BUY
$145.58 - $192.14 $560,046 - $739,162
3,847 Added 24.65%
19,454 $2.83 Million
Q2 2021

Jul 30, 2021
BUY
$134.22 - $202.37 $660,630 - $996,065
4,922 Added 46.06%
15,607 $3.06 Million
Q1 2021

May 07, 2021
BUY
$140.25 - $196.86 $860,293 - $1.21 Million
6,134 Added 134.78%
10,685 $1.93 Million
Q4 2020

Feb 12, 2021
BUY
$126.47 - $163.7 $575,564 - $744,998
4,551 New
4,551 $644,000

Others Institutions Holding TXG

# of Institutions
352
Shares Held
118M
Call Options Held
266K
Put Options Held
191K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email